News Observer -
9 Feb 2014 03:00
Biotechnology companies, a mainstay of the Triangle economy, have been finding favor with a wide swath of investors. Durham's Argos Therapeutics went public last week, and a second Triangle biotech…
Share this Article
Comment on this Article
Please to comment